Cannapharmarx, Inc. financial data

Symbol
CPMD on OTC
Industry
Pharmaceutical Preparations
Location
Suite 3600, 888 3 Rd Street Sw, Calgary, Alberta, Canada
State of incorporation
DE
Fiscal year end
December 31
Former names
GOLDEN DRAGON HOLDING CO. (to 10/27/2014), CCVG, INC. (to 1/12/2011), CONCORD VENTURES, INC. (to 11/17/2010), CAVION TECHNOLOGIES INC (to 7/25/2007)
Latest financial report
10-K - Q4 2024 - Apr 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.66 % +408%
Debt-to-equity -144 % +49.5%
Return On Equity 51.7 %
Return On Assets -78.8 % +45.3%
Operating Margin -6.39K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 663M shares
Common Stock, Shares, Outstanding 663M shares +50.3%
Entity Public Float 9.28M USD
Common Stock, Value, Issued 66.3K USD +50.3%
Weighted Average Number of Shares Outstanding, Basic 351M shares +19.7%
Weighted Average Number of Shares Outstanding, Diluted 663M shares +125%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 312K USD
General and Administrative Expense 51.2K USD -84.8%
Operating Income (Loss) -498K USD +25.4%
Nonoperating Income (Expense) 686K USD +566%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.24M USD +31%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.91M USD -369%
Earnings Per Share, Basic -0.03 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.16K USD +232%
Accounts Receivable, after Allowance for Credit Loss, Current 14.1K USD
Inventory, Net 996K USD -12.1%
Other Assets, Current 0 USD -100%
Assets, Current 1.02M USD -14.8%
Property, Plant and Equipment, Net 137K USD -15%
Operating Lease, Right-of-Use Asset 5.16M USD -12.1%
Assets 10.8M USD -7.75%
Accounts Payable, Current 4.78M USD -2.96%
Accrued Liabilities, Current 4.3M USD +11.7%
Liabilities, Current 25.8M USD +37.5%
Liabilities 30.6M USD +28.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 556K USD
Retained Earnings (Accumulated Deficit) -101M USD -10.9%
Stockholders' Equity Attributable to Parent -19.8M USD -63%
Liabilities and Equity 10.8M USD -7.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -549K USD +10.3%
Net Cash Provided by (Used in) Financing Activities 560K USD +13.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 663M shares +50.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.4K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.16K USD +232%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 0 USD -100%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 84K USD
Property, Plant and Equipment, Gross 211K USD +0.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.17 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 24.6M USD +3.07%
Additional Paid in Capital 80.1M USD +4.77%
Depreciation, Depletion and Amortization 23K USD +295%
Deferred Tax Assets, Net of Valuation Allowance 25M USD +3.2%
Interest Expense 632K USD +78%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%